We are live on ! Find out more
SIC

Starr International Company Portfolio holdings

AUM $19.9M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
-26.43%
1 Year Est. Return
-39.69%
3 Year Est. Return
-26.08%
5 Year Est. Return
-43.79%
10 Year Est. Return
-39.24%
AUM
$48M
AUM Growth
-$18.1M
Cap. Flow
+$152K
Cap. Flow %
0.32%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
BCSF icon
Bain Capital Specialty
BCSF
+$152K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 73.55%
2 Financials 26.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
1
Celularity
CELU
$22M
$35.3M 73.55%
1,528,139
BCSF icon
2
Bain Capital Specialty
BCSF
$823M
$9.89M 20.61%
824,503
+10,692
+1% +$152K
AIG icon
3
American International
AIG
$42.8B
$2.8M 5.84%
59,040

Similar funds

Starr International Company's Q3 2022 Portfolio in Review

As of Q3 2022, Starr International Company held 3 positions worth $48M, down 27% from $66.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Starr International Company opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 79% a quarter earlier, followed by Financials.

  • Starr International Company added most to Bain Capital Specialty in Q3 2022, an estimated $152K increase.
  • Starr International Company's ten largest holdings make up 100% of its $48M portfolio in Q3 2022.
  • Starr International Company opened 0 new positions and closed 0 in Q3 2022.
  • Starr International Company's portfolio value fell 27% quarter-over-quarter to $48M.

Based on Starr International Company's 13F filing for Q3 2022, filed 31 Oct 2022.